MedTrace Logo

Vitamin K Supplementation in Post-Menopausal Osteopenia

NCT00150969 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2023-12-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether supplementation with 5 mg vitamin K daily over a 2-year period will prevent bone loss in post-menopausal women with osteopenia.

Conditions

  • Post-Menopausal Osteoporosis
  • Post-Menopausal Osteopenia

Interventions

DIETARY_SUPPLEMENT

vitamin K1 (phylloquinone)

DIETARY_SUPPLEMENT

placebo

1 pill daily

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Angela M Cheung, MD, PhD · University Health Network, University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2006-09-30
Completion
2007-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00150969 on ClinicalTrials.gov